Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Tumor Pseudoprogression With FLT-PET and MRI
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Radiosurgery Plus Bevacizumab in Glioblastoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
- Status
- COMPLETED
- Phase
- PHASE1
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
- Status
- COMPLETED
- Phase
- PHASE1
Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma
- Status
- TERMINATED
- Phase
- PHASE2
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function
- Status
- COMPLETED
- Phase
- N/A
Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2